NCT04080843 2022-07-13
ALTER-C-002
Zhejiang University
Phase 2 Completed
Clinical Trials
13 trialsNCT03332498 2022-06-03
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Completed
NCT01966289 2021-03-30
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT02981524 2021-02-10
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04287335 2020-12-08
CLEAR-C
Zhejiang University
Completed
NCT02955901 2019-07-16
3-day vs. 1-day Low Residue Diet Influence in Colonoscopy Preparation and Patient Tolerability
Portuguese Oncology Institute, Coimbra
Phase NA Completed
NCT03139942 2019-04-16
OPTIC
Imperial College London
Phase NA Completed
NCT02485561 2018-11-15
Evaluating Strategies to Present Colon Cancer Screening Information
Washington University School of Medicine
Phase NA Completed
NCT03072472 2018-09-06
B-ADENOMA
South Tyneside and Sunderland NHS Foundation Trust
Phase NA Completed
NCT01177007 2017-08-28
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Phase 2 Completed
NCT02401802 2017-02-15
DIETCOL
Parc de Salut Mar
Phase NA Completed
NCT00487409 2014-12-15
Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery
University Hospitals Cleveland Medical Center
Phase NA Completed
NCT00250029 2011-09-27
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
New Mexico Cancer Research Alliance
Phase NA Completed